Showing posts with label Molecular Diagnostics. Show all posts
Showing posts with label Molecular Diagnostics. Show all posts

Thursday, 24 May 2018

Analysis of Molecular Diagnostics Market in Global Industry : Market Development and Overview 2018-2025

ResearchMoz presents professional and in-depth study of "Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025".

This report on the molecular diagnostics market studies the current and future prospects of the market globally. Growing incidences of chronic infectious diseases such as tuberculosis, HIV/AIDS, diarrhea, pneumonia hepatitis, in addition to increasing geriatric population, and rising number of biotechnology companies is expected to accentuate the growth of global molecular diagnostics market.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=186979

The global molecular diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global molecular diagnostics market with respect to market segments based on technology, application, end user and their geographic analysis.

Global Molecular Diagnostics Market: Segmentation

Based on technology, the molecular diagnostics market has been segmented into six major categories: PCR and real-time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing and others which includes mass spectrometry etc. These are the major techniques which are used in molecular diagnostics for diagnosis of disease. Likewise, on the basis of application, the global molecular diagnostics market has been segmented into infectious diseases, oncology, blood screening, microbiology, genetic testing and women’s health. Infectious disease testing has been segmented into two major categories, namely, virology and bacteriology. The market segments have been extensively analyzed based on usefulness, adoption, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2015 to 2025. The molecular diagnostics market report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2015 as the base year. A brief patient pool analysis by infectious disease, cancer and cardiovascular disease have also been discussed in the global molecular diagnostics report.

Based on End User the global molecular diagnostics market is segmented as hospitals, diagnostic laboratories, blood banks, academics & research and others. The market size and forecast for each of these end user has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year.

View Complete TOC with tables & Figures @ https://www.researchmoz.us/molecular-diagnostics-market-pcr-next-generation-sequencing-microarray-infectious-diseases-genetic-disease-oncology-testing-blood-donor-screening-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-report.html/toc

Global Molecular Diagnostics Market: Regional Outlook

Geographically, the molecular diagnostics market in Europe has been categorized into five major regions:   North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving that is supply side driver, demand side driver and economic driver, restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players, competitive matrix thus presenting a thorough analysis of the overall competitive scenario in the global molecular diagnostics market.

Key Players Mentioned in this Report are:

Current and future trends has also been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the global molecular diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments, SWOT analysis. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN N.V. ,bioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG and Thermo Fisher Scientific Inc., and others.

The global molecular diagnostics market is segmented as given below:

Global Molecular Diagnostics Market, by Technology

    PCR and Real-Time PCR
    Hybridization
    Microarray
    Transcription-Mediated Amplification
    Next-Generation Sequencing
    Others (Mass Spectrometry, etc.)

Global Molecular Diagnostics Market, by Application

    Infectious Diseases
    Oncology
    Blood Screening
    Microbiology
    Genetic Testing
    Women’s Health

Global Molecular Diagnostics Market, by End Use

    Hospitals
    Diagnostic Laboratories
    Blood Banks
    Academics
    Research

Global Molecular Diagnostics Market, by Region

    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Spain
    Rest of Europe
    Asia Pacific
    China
    Japan
    Australia
    India
    Rest of Asia Pacific
    Latin America
    Brazil
    Mexico

Browse Report @ https://www.researchmoz.us/molecular-diagnostics-market-pcr-next-generation-sequencing-microarray-infectious-diseases-genetic-disease-oncology-testing-blood-donor-screening-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-report.html

    Rest of Latin America
    Middle East & Africa
    Saudi Arabia
    South Africa
    Rest of Middle East & Africa

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Tuesday, 20 February 2018

Overview of Molecular Diagnostics Market with Focus on Infectious Diseases (HPV/Chlamydia) & Genetic Testing : Global Industry Demands, Insights, Research and Forecast to 2020

ResearchMoz presents professional and in-depth study of "Global Molecular Diagnostics Market with Focus on Infectious Diseases (HPV/Chlamydia) & Genetic Testing: Industry Analysis & Outlook (2016-2020)".

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=827476

In vitro diagnostics (IVD) are the medical tests which are intended to perform diagnoses from sample of body fluids in a controlled environment outside a living organism. In vitro diagnostic (IVD) tests are performed to conduct diagnoses from assays in a test tube, or in a controlled environment outside a living organism.

Molecular Diagnostics is a technology used in the process of in vitro diagnosis. Molecular diagnostics involves the measurement of DNA, RNA, proteins or metabolites in order to detect genotypes, mutations or biochemical changes in the body. Molecular diagnostics market is escalating beyond the identification of infections. It is becoming an essential part of disease management and therapy. The variety of technologies used in molecular diagnostics has transformed clinical laboratory medicine. The market is further expected to see a robust growth with increased research and development.

The global molecular diagnostics market is expected to see innovation driven growth. With recent outbreak of infectious diseases like Ebola and swine flu, they would require accurate diagnostics, which will instigate the growth of the molecular diagnostics technology in the future, thereby posing tremendous growth potential for the market. Asia-Pacific is expected to register the highest growth rate in expansion of molecular diagnostics in the coming years.

View Complete TOC with tables & Figures @ https://www.researchmoz.us/global-molecular-diagnostics-market-with-focus-on-infectious-diseases-hpvchlamydia-genetic-testing-industry-analysis-outlook-20162020-report.html/toc

The key factors driving growth of the MD market includes fast approvals for companion diagnostics reagents, increase in emergence of infectious disease, innovation and technical development, rising ageing population, and escalating global healthcare expenditure. However, there are certain factors hindering the growth of the market like high initial cost, obligation of skilled labor, and lack of proper healthcare infrastructure. The major trends featuring the market includes increasing clinical microbiological laboratories in developing nations, next generation sequencing, and increase in sale of point of care devices.

The report offers an in-depth analysis of the Global Molecular Diagnostics Market with focus on Infectious Diseases (HPV/Chlamydia) & Genetic Testing. It covers the regional and global aspect of the market. Competition is concentrated in the hands of few major companies, of which Roche Holding, Abbott Laboratories, Hologic Inc., and Qiagen have been covered in the report.

Table of Content

1. Market Overview
1.1 Diagnostics
1.2 Molecular Diagnostics
1.3 Purpose of Molecular Diagnostics

2. Global In Vitro Diagnostics (IVD) Market
2.1 Global IVD Market by Value
2.2 Global IVD Market Forecast by Value
2.3 Global IVD Market by Segment
2.4 Global IVD Market by Technology

Browse Report @ https://www.researchmoz.us/global-molecular-diagnostics-market-with-focus-on-infectious-diseases-hpvchlamydia-genetic-testing-industry-analysis-outlook-20162020-report.html

3. Global Molecular Diagnostics (MD) Market
3.1 Global MD Market by Value
3.2 Global MD Market Forecast by Value
3.3 Global MD Market by Application
3.4 Global MD Market Forecast by Region
3.5 Global MD Market by Test Type
3.5.1 Global HPV Market by Value & Volume
3.5.2 Global HPV Market Forecast by Value & Volume
3.5.3 Global CT/NG Market by Value & Volume
3.5.4 Global CT/NG Market Forecast by Value & Volume
3.5.5 Global Genetic Testing Market by Value
3.5.6 Global Genetics Testing Market Forecast by Value

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Tuesday, 22 August 2017

Overview of Molecular Diagnostics Market in Global Industry : Demands, Insights, Research and Forecast 2017-2021

ResearchMoz presents professional and in-depth study of "Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth Trends & Forecast to 2021".

Molecular Diagnostics has emerged as one of the largest and fastest growing segment in the IVD industry. It is the most dynamic and transformative areas of diagnostics, leading to advances in research and treatment that are revolutionizing healthcare across a wide range of diseases and health conditions and has been driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost–effective testing.

The global molecular diagnostics market is projected to reach more than US$ 30 Billion by 2021, at a CAGR of XX% from 2016 to 2021.The global market is mainly driven by chronic infections, growing geriatric population, increasing demand for personalized medicines, and R&D activities for biomarker identification equipped with emergence of new technology and applications. In addition, innovations in molecular diagnostics for treating cancer, government support for research and development, and high patient awareness levels are driving the growth of molecular diagnostic market

North America dominates the global market of molecular diagnostics due to increasing incidence of infectious diseases and lifestyle associated diseases. North America controls more than 40% of the market share by the year 2021. Japan, China and India is expected to show high growth rates in the next six years in molecular diagnostics market.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=747470

On the basis of application, Molecular oncology tests have emerged as a significant rapidly growing market segment.  Oncology test controls nearly 25% market share by the year 2021.

Other segments such as infectious diseases test and genetic testing is poised to be remarkable expansion in the near future. Growing demand for infectious diseases and genetic tests is an opportunity for global molecular diagnostics market.

In terms of technology, Biochips/Microarrays is the fastest growing segment and is expected to boom further within the forecast period. FISH & Innovations and PCR based test is expected to grow at the highest CAGR in the coming years.

On the basis of company, Roche is the leading company with more than 30% market share in the global molecular diagnostics market and is expected to hold its strong position in the market. Becton Dickinson, Myriad Genetics, Abbott and Qiagen is expected to robust market growth in the global molecular diagnostics market.
The Research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically–supported and industry–validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as 1) Market and Forecast 2) Application Wise Market & Forecast 3) Geographical Market & Forecast 4) Technology Wise Market & Forecast 5) Company Wise Molecular Diagnostics Sales & Forecast 6) Market Growth Drivers & Challenges

Make an Enquiry about TOC @ http://www.researchmoz.us/enquiry.php?type=E&repid=747470

Global Molecular Diagnostics Market has been analyzed from 6 viewpoints:

    Market and Forecast
    Application Wise Market & Forecast
    Geographical Market & Forecast
    Technology Wise Market & Forecast
    Company Wise Molecular Diagnostics sales & Forecast
    Market Growth Drivers & Challenges

The following application segments of the molecular diagnostics market are detailed with size and six year forecast.

    Infectious Disease Testing
    Cardiovascular Disease Testing
    Oncology Testing
    Neurological Disorders Testing
    Food Pathogen Detection Testing
    Genetic Testing
    Blood Screening
    Tissue Typing (HLA Testing)
    Others Molecular Testing

Furthermore, the following technology segments of the molecular diagnostics market are detailed with size and six year forecast.

    PCR Based Test
    PCR Related Technologies
    Non–PCR Test
    Fish & Innovations Testing
    Biochips/Microarrays
    Biosensors
    Molecular Imaging
    Other Technologies

The report analyses the market based on regions and presents the forecast in terms of value for the next six years. Regions covered in the report include:

    North America
    Europe
    Japan
    China
    India
    Brazil
    Mexico
    Korea
    Rest of the world

Browse Report @ http://www.researchmoz.us/molecular-diagnostics-market-global-industry-analysis-size-share-growth-trends-forecast-to-2021-report.html

The following companies of the molecular diagnostics market are detailed with size and six year forecast.

    Roche
    Abbott Laboratories
    Myriad Genetics
    Qiagen
    Cephied
    Becton Dickinson
    Biomerieux
    Other Companies

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/